⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

BDX

Becton, Dickinson and Company

Healthcare · Medical Instruments & Supplies

179.80USD

+1.7500 (+0.98%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$4.07▼$4.0837
Next quarter$2.73▼$2.8107
Current year$12.62▲$12.54110
Next year$13.29▼$13.419

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$3.14$3.23+0.09 (+2.9%)
2026-03-31$2.77$2.9+0.13 (+4.5%)
2025-12-31$2.81$2.91+0.10 (+3.5%)
2025-09-30$3.91$3.96+0.05 (+1.1%)

Wall Street coverage

221 ratings from 29 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
B of A SecuritiesMaintainedNeutral$185 $200Aug 31, 2026
RBC CapitalMaintainedSector Perform$180 $190Aug 13, 2026
CitigroupMaintainedBuy$198 $204Aug 7, 2026
RBC CapitalMaintainedSector Perform$175 $180Aug 7, 2026
Piper SandlerMaintainedNeutral$161 $175Aug 7, 2026
Wells FargoMaintainedEqual-Weight$161 $170Aug 7, 2026
TD CowenMaintainedHold$163 $182Aug 5, 2026
UBSInitiatedBuy$190Jul 28, 2026
Evercore ISI GroupMaintainedOutperform$190 $180Jul 6, 2026
BarclaysMaintainedOverweight$202 $204May 11, 2026
Wells FargoMaintainedEqual-Weight$157 $161May 8, 2026
TD CowenMaintainedHold$189 $163May 4, 2026
Piper SandlerMaintainedNeutral$170 $159Apr 17, 2026
Argus ResearchMaintainedBuy$230 $180Mar 23, 2026
CitigroupMaintainedBuy$232 $198Feb 11, 2026
JP MorganMaintainedNeutral$190 $175Feb 10, 2026
JefferiesMaintainedBuy$220 $190Feb 10, 2026
RBC CapitalMaintainedSector Perform$210 $172Feb 10, 2026
CitigroupMaintainedBuy$233 $232Feb 10, 2026
Piper SandlerReiteratedNeutral$205 $170Feb 10, 2026
Wells FargoMaintainedEqual-Weight$184 $157Feb 10, 2026
Piper SandlerMaintainedNeutral$190 $205Jan 28, 2026
StifelMaintainedBuy$210 $215Jan 7, 2026
B of A SecuritiesMaintainedNeutral$190 $207Jan 5, 2026
RBC CapitalMaintainedSector Perform$202 $210Dec 17, 2025

Insider transactions

100 filings from 30 insiders · 6 buy / 11 sell over 6m

Officers and directors of BDX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Roque VitorOfficer, EVP & Chief Financial OfficerTax190——Sep 2, 2026
FELD MICHAELOfficerSell165$188.49$31kAug 26, 2026
POLEN THOMAS E JRChief Executive OfficerExercise43.3k$167.25$7.24MAug 13, 2026
POLEN THOMAS E JRChief Executive OfficerSell4.2k$185.00$768kAug 13, 2026
GOETTE ROLANDOfficerSell2.4k$180.84$441kAug 11, 2026
FELD MICHAELOfficerSell75$157.13$12kJul 27, 2026
MUHSIN BILALOfficerGrant14.3k——Jul 1, 2026
FELD MICHAELOfficerSell75$152.80$11kJun 26, 2026
GARRISON MICHAEL DAVIDOfficerSell1.1k$145.66$160kJun 24, 2026
GARRISON MICHAEL DAVIDOfficerSell1.1k$151.48$167kJun 10, 2026
POLEN THOMAS E JRChief Executive OfficerExercise20.2k$126.16$2.55MJun 1, 2026
POLEN THOMAS E JRChief Executive OfficerSell2.8k$146.35$405kJun 1, 2026
MENZIUSO PETEROfficerGrant14.3k——Jun 1, 2026
FELD MICHAELOfficerSell75$147.35$11kMay 26, 2026
ROQUE VITORChief Financial OfficerGrant1.7k——May 7, 2026
FELD MICHAELOfficerSell74$151.94$11kApr 27, 2026
FELD MICHAELOfficerSell75$156.83$12kMar 26, 2026
MINNIX LANESHAGeneral CounselGrant7.5k——Mar 16, 2026
SPIKNER PAMELA LOfficerGrant931——Mar 2, 2026
ROQUE VITORChief Financial OfficerGrant931——Mar 2, 2026

Analyst Notes

Sign in to write

No analyst notes on BDX yet.

Analyst Ratings

12 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current16700Buy2.43
1 mo ago16700Buy2.43
2 mo ago16700Buy2.43
3 mo ago06800Hold2.57
Price target$195.67$170.00 – $225.00
+8.8% to target